Patient Journey in Advanced Gynecologic Cancers

Tongji Hospital

Status

Not yet enrolling

Conditions

Endometrial Carcinoma

Uterine Cervical Neoplasms

Genital Neoplasms, Female

Treatments

Other: interview

Study type

Observational

Funder types

Other

Identifiers

NCT07015593

NIS103233

[2024]S257 (Other Identifier)

Details and patient eligibility

About

This is a mixed-methods survey study including a 2-phased sequential-explanatory design. This study is to understand the patient journey in conventional therapy for newly diagnosed stage III or IV CC or EC in China, including ①patients' treatment decision making factors and treatment experiences and ② patients' unmet needs during post-treatment surveillance.

Full description

This is a mixed-methods survey study including a 2-phased sequential-explanatory design: Phase 1, Qualitative interview will be done first to explore the treatment decision factors, treatment experiences and unmet needs during post treatment surveillance, to provide components and inform the quantitative data collection. Phase 2, quantitative survey to collect data on a larger scale and allow a statistical generation of the qualitative findings.

Enrollment

780 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age 18 or older
Newly diagnosed stage III or IV CC or EC
Completed their initial conventional therapies which must include at least chemotherapy, radiotherapy or a combination between Dec. 2022 to Dec. 2024 and the therapies were within 6 months after diagnosis.
Told by their physician that their disease is stable.
Patients must have informed consent form (ICF) signed for the study.

Exclusion criteria

Previously treated with targeted biologic therapy anti-PD-1, anti-PD-L1, or anti PD-L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor.
Previously participated in or participating in a clinical trial.
Patients who received another line of therapy after initial therapy.
Unable or unwilling to provide informed consent.
Not fluent in local language.
Indicates or exhibits hearing difficulties, which would make a conversation challenging.